Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinoma

Jun Sik Yoon, Gyeonghwa Kim, Yu Rim Lee, Soo Young Park, Won Young Tak, Young Oh Kweon, Jung Gil Park, Hye Won Lee, Young Seok Han, Heon Tak Ha, Jae Min Chun, Se Young Jang, Keun Hur

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Aim: Aberrant microRNA (miR) expression is associated with hepatocellular carcinoma (HCC). Materials & methods: Here, we investigated the clinical significance of miR-21 and miR-31 for HCC-specific prognostic effect. HCC patients (n = 93) who underwent liver biopsy or surgical resection were enrolled, and HCC tissues and paired adjacent nontumor liver tissues were collected and analyzed for miRs expression. Results: MiR-21 expression was significantly upregulated in HCC tissues relative to nontumor tissues. Both miR-21 and miR-31 expression in HCC tissues did not predict overall survival; however, miR-21 was considered an independent predictor of disease progression together with portal vein thrombosis and higher Barcelona Clinical Liver Cancer stage. Conclusion: Elevated miR-21 expression might represent a biomarker for HCC prognosis.

Original languageEnglish
Pages (from-to)1105-1114
Number of pages10
JournalBiomarkers in Medicine
Volume12
Issue number10
DOIs
StatePublished - Oct 2018

Keywords

  • disease progression
  • hepatocellular carcinoma
  • microRNA-21
  • microRNA-31
  • prognosis
  • survival
  • therapeutics

Fingerprint

Dive into the research topics of 'Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this